Business Segments · Selling, general, and administrative
Medical Devices — Selling, general, and administrative
Abbott Medical Devices — Selling, general, and administrative increased by 0.1% to $1.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $1.29B to $1.39B. Over 3 years (FY 2022 to FY 2025), Medical Devices — Selling, general, and administrative shows an upward trend with a 10.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toSG&A
How to read this metric
Lower spending relative to revenue suggests improved operational efficiency and better cost management.
Detailed definition
Represents the overhead costs associated with operating the medical devices segment, including sales force compensation,...
Peer comparison
Standard SG&A expense metric used across all industries.
Metric ID:
abt_segment_medical_devices_selling_general_and_administrativeHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $1.02B | $1.02B | $1.02B | $1.10B | $1.10B | $1.10B | $1.10B | $1.18B | $1.22B | $1.22B | $1.26B | $1.29B | $1.39B | $1.39B | $1.39B | $1.39B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +8.5% | +0.0% | +0.0% | +0.0% | +6.7% | +3.7% | +0.0% | +3.1% | +2.2% | +7.6% | +0.4% | -0.2% | +0.1% |
| YoY Change | — | — | — | — | +8.5% | +8.5% | +8.5% | +8.5% | +6.7% | +10.6% | +10.6% | +14.0% | +9.3% | +13.4% | +13.8% | +10.2% | +7.8% |
Range$1.02B – $1.39B
CAGR+8.1%
Avg YoY Growth+10.0%
Median YoY Growth+9.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's medical devices — selling, general, and administrative?
- Abbott (ABT) reported medical devices — selling, general, and administrative of $1.39B in Q1 2026.
- How has Abbott's medical devices — selling, general, and administrative changed year-over-year?
- Abbott's medical devices — selling, general, and administrative increased by 7.8% year-over-year, from $1.29B to $1.39B.
- What is the long-term trend for Abbott's medical devices — selling, general, and administrative?
- Over 3 years (2022 to 2025), Abbott's medical devices — selling, general, and administrative has grown at a 10.2% compound annual growth rate (CAGR), from $4.07B to $5.45B.
- What does medical devices — selling, general, and administrative mean?
- The operating expenses related to selling products and managing the business, excluding production costs.